Watson’s Levetiracetam Extended-Release 500mg and 750mg tablets are generic equivalent to Keppra XR of UCB.
Keppra is an anti-epileptic drug which is indicated for the treatment of partial onset seizures in patients 16 years of age and older with epilepsy.
The launching of the drug follows approval from the US Food and Drug Administration (FDA) for Levetiracetam Extended-Release 500mg and 750mg tablets’ abbreviated new drug application (ANDA).